Biochemical alteration of membrane-associated IL-6 RI (80-kDa) in adherent macrophages and vascular endothelium

Molecular Immunology

Volumn 38, Issue 5, 2001, Pages 347-357

  Coyne, C P ^a   Howell, Trey ^a   Baravick, Jeff ^a   Baravick, Erica ^a   Willetto, Carla ^a,c   Fenwick, Brad W ^b  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c Ilisagvik College   (United States)

Author keywords

Cytokine receptors; Enzyme proteases; IL 6 RI (80 kDa); Macrophages; Shedding events; Vascular endothelium

Indexed keywords

ASPARTIC PROTEINASE; CALCIMYCIN; CARBOXYL GROUP; CATHEPSIN D; CYSTEINE PROTEINASE; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; PEPSTATIN; PROTEINASE INHIBITOR; THIOL PROTEINASE;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; CATTLE; CONTROLLED STUDY; FEMALE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; ASPARTIC ENDOPEPTIDASES; BUFFERS; CALCIMYCIN; CATHEPSIN D; CATTLE; CELL ADHESION; CELL MEMBRANE; CITRATES; CYSTEINE PROTEINASE INHIBITORS; ENDOTHELIUM, VASCULAR; FEMALE; LEUCINE; MACROPHAGES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PEPSTATINS; RECEPTORS, INTERLEUKIN-6;

EID: 0034776772     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00074-8     Document Type: Article

References (33)

1. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors
2. An improved cathepsin-D substrate and assay procedure
3. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins
4. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation
5. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock
6. Synthesis and secretion of procathepsin-B and cystatin-C by human bronchial epithelial cells in vitro: Modulation of cathepsin-B activity by neutrophil elastase
7. Human sputum cathepsin-B degrades proteoglycan, is inhibited by α-2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin-B precursor and cystatin-C
8. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex
9. Isolation of an inhibitor of tumor necrosis factor-α from activated mixed equine white blood cell populations
10. In vitro activation of pro-cathepsin-B by three serine proteinases: Leukocyte elastase, cathepsin-G and the urokinase-type plasminogen activator
11. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity
12. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes
13. A metalloprotease inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cell
14. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses
15. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it in inhibits TNF production
16. Analysis of where and which types of proteinases participate in lysosomal proteinases processing using bafilomycin A1 and Heliobacter pylori Vac A toxin
17. Isolation of cathepsin-D using three-phase partitioning in t-butanol/water/ammonium sulfate and pepstatin-A affinity chromatography
18. Experimental autoimmune encephalomyelitis is exacerbated by IL-1-α and suppressed by soluble IL-1 receptor
19. Tumor necrosis factor-α and interleukin-1-α stimulate late shedding of p75 receptors but not p55 TNF receptors from human monocytes
20. Identification of the proteolytic enzyme which cleaves human p75 receptor in vivo
21. Cytokine (IL-8, IL-6, TNF-α) and soluble TNF receptor-I release from human peripheral blood monocytes after respiratory syncytial virus infection
22. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells
23. The soluble interleukin-6 receptor is generated by shedding
24. A metaloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
25. IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor
26. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes
27. Plasminogen activator production by bovine milk macrophages and blood monocytes
28. Human neutrophil elastase release and ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor
29. Lipopolysaccharide-mediated induction of the bovine interleukin-6 gene in monocytes requires both NF-κB and C/EBP binding sites
30. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition
31. Proteolytic activation of human procathepsin-D
32. Tumor necrosis factor soluble receptor 75: The principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon (γ)